COLLABORATION AGREEMENTCollaboration Agreement • July 31st, 2014 • Exelixis, Inc. • Services-commercial physical & biological research • New York
Contract Type FiledJuly 31st, 2014 Company Industry JurisdictionThis Collaboration Agreement (the “Agreement”) is made and entered into as of May 27, 2009 (the “Effective Date”) by and between Exelixis, Inc., a Delaware corporation having an address at 170 Harbor Way, P.O. Box 511, South San Francisco, California 94083-0511 (“Exelixis”), and Sanofi-Aventis, a French company, having an address at 174, Avenue de France, 75013 Paris, France (“Sanofi-Aventis”). Exelixis and Sanofi-Aventis are sometimes referred to herein individually as a “Party” and collectively as the “Parties”.
COLLABORATION AGREEMENTCollaboration Agreement • December 18th, 2009 • Exelixis Inc • Services-commercial physical & biological research • New York
Contract Type FiledDecember 18th, 2009 Company Industry JurisdictionTHIS COLLABORATION AGREEMENT (the “Agreement”) is made and entered into as of May 27, 2009 (the “Effective Date”) by and between EXELIXIS, INC., a Delaware corporation having an address at 170 Harbor Way, P.O. Box 511, South San Francisco, California 94083-0511 (“Exelixis”), and SANOFI-AVENTIS, a French company, having an address at 174, Avenue de France, 75013 Paris, France (“Sanofi-Aventis”). Exelixis and Sanofi-Aventis are sometimes referred to herein individually as a “Party” and collectively as the “Parties”.